A population-based comparison of adenocarcinoma of the large and small intestine: Insights into a rare disease

Annals of Surgical Oncology

Volumn 19, Issue 5, 2012, Pages 1439-1445

  Overman, Michael J ^a   Hu, Chung Yuan ^a   Kopetz, Scott ^a   Abbruzzese, James L ^a   Wolff, Robert A ^a   Chang, George J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; FEMALE; HUMAN; LARGE INTESTINE ADENOCARCINOMA; LARGE INTESTINE CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RARE DISEASE; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; DUODENAL NEOPLASMS; FEMALE; HUMANS; ILEAL NEOPLASMS; INCIDENCE; JEJUNAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; SURVIVAL RATE; YOUNG ADULT;

EID: 84862578454     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2173-6     Document Type: Article

References (35)

1. Bilimoria KY, Bentrem DJ, Wayne JD, et al. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63-71.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
3. Agrawal S, McCarron EC, Gibbs JF, et al. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol. 2007;14:2263-9. (Pubitemid 47174924)
4. Howe JR, Karnell LH, Menck HR, Scott-Conner C; The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999;86:2693-706. (Pubitemid 30004674)
5. Wu TJ, Yeh CN, Chao TC, et al. Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg. 2006;30:391-8.
6. Overman MJ, Varadhachary GR, Kopetz S, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009;27:2598-603.
7. Sellner F. Investigations on the significance of the adenomacarcinoma sequence in the small bowel. Cancer. 1990;66: 702-15. (Pubitemid 20281314)
8. Perzin KH, Bridge MF. Adenomas of the small intestine: a clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer. 1981;48:799-819. (Pubitemid 11075239)
9. Blaker H, von Herbay A, Penzel R, et al. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene. 2002;21: 158-64. (Pubitemid 34076389)
10. Nishiyama K, Yao T, Yonemasu H, et al. Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine. Oncol Rep. 2002;9:293-300.
11. Zhang MQ, Chen ZM, Wang HL. Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma. Mod Pathol. 2006;19:573-80.
12. Blaker H, Helmchen B, Bonisch A, et al. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Scand J Gastroenterol. 2004;39:748-53. (Pubitemid 39093249)
13. Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology. 1997;113:127-35. (Pubitemid 27281766)
14. Arai M, Shimizu S, Imai Y, et al. Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer. 1997;70:390-5. (Pubitemid 27107264)
15. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res. 1994;54:3011-20. (Pubitemid 24187789)
16. Miyoshi Y, Nagase H, Ando H, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet. 1992;1:229-33.
17. River L, Silverstein J, Tope JW. Benign neoplasms of the small intestine; a critical comprehensive review with reports of 20 new cases. Surg Gynecol Obstet. 1956;102:1-38.
18. O'Riordan BG VM, Herrera L. Small bowel tumors: an overview. Dig Dis. 1996;14:245-57. (Pubitemid 126484434)
19. DeSesso JM, Jacobson CF. Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol. 2001;39:209-28. (Pubitemid 32244129)
20. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
21. Overman MJ, Hu CY, Wolff RA, Chang GJ. Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2010;116:5374-82.
22. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434-7. (Pubitemid 29128279)
23. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-81. (Pubitemid 24015040)
24. Neugut AI, Jacobson JS, Suh S, et al. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev. 1998;7:243-51. (Pubitemid 28353936)
25. Scélo G, Boffetta P, Hemminki K, et al. Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer. 2006;118:189-96. (Pubitemid 41681598)
26. Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev. 1994;3:205-7. (Pubitemid 24172531)
27. Wu AH, Yu MC, Mack TM. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer. 1997;70:512-7. (Pubitemid 27149633)
28. Lowenfels AB, Sonni A. Distribution of small bowel tumors. Cancer Lett. 1977;3:83-6. (Pubitemid 8152924)
29. Kaerlev L, Teglbjaerg PS, Sabroe S, et al. Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center case-control study. Cancer Causes Control. 2000;11:791-7.
30. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433-41. (Pubitemid 47073566)
31. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22:2781-9. (Pubitemid 41079895)
32. Petrik DW, McCready DR, Sawka CA, Goel V. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. J Surg Oncol. 2003;82:84-90. (Pubitemid 36164441)
33. Nicholl MB, Ahuja V, Conway WC, et al. Small bowel adenocarcinoma: understaged and undertreated? Ann Surg Oncol. 2010;17:2728-32.
34. Howlader N, Ries LA, Mariotto AB, et al. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584-98.
35. Lund JL, Harlan LC, Yabroff KR, Warren JL. Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease. Cancer Invest. 2010;28:758-64.